IDH2 and oligodendroglioma: Those observations, in combination with previous reports, lead to the conclusion that co-occurrence of mutations in IDH and the TERT promoter reflect a mutational signature of oligodendrogliomas, whereas the presence of either TERT promoter or IDH mutations is a feature of astrocytic progression [25, 37].